Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-07-19
2005-07-19
Balasubramanian, Venkataraman (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S275000, C544S310000, C544S318000, C544S320000, C544S321000, C544S324000, C544S326000, C544S328000, C544S331000
Reexamination Certificate
active
06919347
ABSTRACT:
Bradykinin B1-receptor antagonists of formulaare disclosed. The compounds are useful for treating diseases associated with inappropriate bradykinin receptor activity, such as diabetic vasculopathy, inflammation, pain, hyperalgesia, asthma, rhinitis, septic shock, atherosclerosis and multiple sclerosis. Pyrimidines, triazines, and anilines in which Q is imidazolyl or pyrrolyl are particularly preferred.
REFERENCES:
patent: 3707560 (1972-12-01), DeAngelis
patent: 6432947 (2002-08-01), Arnaiz et al.
patent: 6670473 (2003-12-01), Arnaiz et al.
patent: 2002/0165203 (2002-11-01), Arnaiz et al.
patent: 2002/0183323 (2002-12-01), Arnaiz et al.
patent: 2003/0004137 (2003-01-01), Arnaiz et al.
patent: 2003/0027794 (2003-02-01), Arnaiz et al.
patent: 2003/0060452 (2003-03-01), Arnaiz et al.
patent: 2003/0069210 (2003-04-01), Arnaiz et al.
patent: 2003/0073669 (2003-04-01), Arnaiz et al.
patent: 2003/0083332 (2003-05-01), Arnaiz et al.
patent: 2003/0092678 (2003-05-01), Arnaiz et al.
patent: 0096657 (1983-12-01), None
patent: 0864567 (1998-09-01), None
patent: WO97/24349 (1997-07-01), None
patent: WO98/37079 (1998-08-01), None
patent: WO98/42672 (1998-10-01), None
patent: WO 01/14371 (2001-03-01), None
Kharitonov et al. Eur. Respir. J. 14(5): 1023-1027, 1999.
Bagate et al., Br. J. Pharmacol. 128(8) : 1643-1650.
Baldwin John J.
Dolle, III Roland E.
Ohlmeyer Michael H. J.
Pan Gonghua
Paradkar Vidyadhar
Balasubramanian Venkataraman
Pharmacopeia Drug Discovery Inc.
Timmer, Esq. Edward
LandOfFree
Bradykinin B1 receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bradykinin B1 receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bradykinin B1 receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3387967